HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection of reperfused ischemic canine myocardium by CI-922, a new inhibitor of leukocyte activation.

Abstract
There is increasing evidence that activated neutrophils cause myocardial injury during reperfusion of ischemic myocardium. This study was performed to assess the effect of Ci-922, an inhibitor of neutrophil activation, in a canine preparation of myocardial infarction. Dogs received 15-min infusions of CI-922 1 mg/kg or 5% dextrose beginning 30 min before occlusion of the left circumflex coronary artery. After occlusion for 90 min and reperfusion for 6 h, infarct size was determined by ex vivo perfusion of the left circumflex coronary artery with triphenyltetrazolium chloride. The percentage of the area at risk infarcted was: control, 42 +/- 5; and CI-922, 23 +/- 4 (p less than 0.05 vs. control). There were no significant inter-group differences in heart rate or mean arterial pressure, and CI-922 did not enhance collateral blood flow to the ischemic bed. After incubation with CI-922 (100 microM), production of superoxide anions by canine neutrophils activated by opsonized zymosam decreased from 3.5 +/- 0.2 to 2.0 +/- 0.4 nmol/10 min/10(6) cells (p less than 0.05). Thus, inhibition of neutrophil-mediated damage may explain the cardioprotective effect of CI-922.
AuthorsS W Werns, B T Eller, M J Shea, P J Simpson, R C Dysko, G D Abrams, B R Lucchesi
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 12 Issue 5 Pg. 608-14 ( 1988) ISSN: 0160-2446 [Print] United States
PMID2468062 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Azoles
  • Indoles
  • Tetrazoles
  • Superoxides
  • CI 922
  • Peroxidase
Topics
  • Animals
  • Azoles (therapeutic use)
  • Coronary Circulation (drug effects)
  • Dogs
  • Electrocardiography
  • Hemodynamics (drug effects)
  • Indoles (therapeutic use)
  • Male
  • Myocardial Reperfusion Injury (prevention & control)
  • Myocardium (enzymology)
  • Neutrophils (metabolism)
  • Peroxidase (metabolism)
  • Superoxides
  • Tetrazoles (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: